Research is a crucial element in understanding and supporting individuals with autism. Today, we’d like to highlight two important research studies open for participation by families within the autism community.
Penguin Autism Study: Treatment for irritable behaviors in children ages 5-17.
The Penguin Autism Study’s purpose is to evaluate an investigational drug to determine if it may treat irritability and other behaviors in children and adolescents with ASD.
Study participation will last for up to 14 weeks, with a 6-week treatment period. Children who enroll in this study will receive either the study drug or placebo. A placebo looks like the study drug but has no impact on the person taking it. There will be no cost for the study drug or any study-related procedures. You may be compensated for your time and travel.
If your child completes the 6-week treatment period, they may be able to enroll in a 52-week, open-label extension study if they qualify. During this open-label study, there is no placebo. Children who enroll will receive the study drug, pimavanserin.
Vagus Nerve Stimulation Trial: Addressing Anxiety in Autism
The second study focuses on treating anxiety in autistic individuals through vagus nerve stimulation. This trial involves the placement of a sticker on the outer part of the ear.
To participate, please call 843-792-9502 or email Nicole Cash (cashni@musc.edu) or Falon Sutton (suttonf@musc.edu).
Participating in research studies like the Penguin Autism Study and the Vagus Nerve Stimulation Trial offers families the chance to be part of initiatives that enhance our understanding and treatment of autism and improve the lives of individuals on the spectrum. Please consider signing up and sharing these opportunities with others.
